NASDAQ:CAPR

Capricor Therapeutics, Inc Earning Date

USA |NASDAQ |USD

CAPR Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 10, 2021 Sep 2021 $-0.22 $-0.21 $-0.20
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 10, 2021 Sep 2021 $210.00K $204.08K $16.86K

Capricor Therapeutics, Inc's next earnings date is Wednesday, Nov 10, 2021 for the fiscal quarter ending Sep 2021.

CAPR Earnings Date & History Chart

CAPR Earnings & Revenue Forecast

CAPR Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $-0.24 $-0.24 $-0.24
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $-0.90 $-0.90 $-0.90
Dec 2022 1 $-0.95 $-0.95 $-0.95

CAPR Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.24 $-0.24 $-0.24
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.90 $-0.96 $-0.96
Dec 2022 0 / 0 $-0.95 $-1.00 $-1.00

CAPR Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 1 $390.00K $390.00K $390.00K
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $570.00K $240.00K $900.00K
Dec 2022 1 $2.00M $2.00M $2.00M

CAPR Earnings Date & Revenue History

CAPR Earnings History

|
Show More
Show More

CAPR Revenue History

|
Show More
Show More

Capricor Therapeutics, Inc Next Earnings Date & Report

CAPR Next Earnings Date & Report Preview: Sep 2021 (FQ)

CAPR's next earnings date is Wednesday, Nov 10, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 1 analysts, the average EPS estimation for Capricor Therapeutics, Inc's next quarterly earnings is $-0.22, with a low EPS estimation of $-0.22, and a high estimation of $-0.22.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.22, the last 2 month trend is $-0.23, and the 3 month trend is $-0.23.

Based on 1 analysts, the average revenue estimation is $210.00K, with a low revenue estimation of $210.00K, and a high estimation of $210.00K.

Capricor Therapeutics, Inc Previous Earnings Dates & Reports

CAPR Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Capricor Therapeutics, Inc's previous earnings date was Aug 12, 2021 for its fiscal quarter ended Jun 30, 2021.

CAPR's earnings per share (EPS) was $-0.21, beating the consensus analysts forecast of $-0.23 by 8.70%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -8.70%, and higher than the same period a year before (Jun 2020) by -8.70%.

Revenues were $204.08K, up by 400.00% from the previous quarter , and up by 309.28% from the same period last year.

The company reported a net income of $-4.75M.

Free cash flow for the quarter was $-4.84M , compared to $-3.37M last quarter and $-2.12M a year before.

CAPR Previous Earnings Date & Report Recap: Dec 2020 (FY)

Capricor Therapeutics, Inc's previous annual earnings date was Mar 11, 2021 for its fiscal year ended Dec 31, 2020.

CAPR's earnings per share (EPS) was $-0.94, missing the consensus analysts forecast of $-0.88 by 6.82% , and higher than the previous year's EPS (Dec 2019) by -56.48%.

Revenues were $310.25K, better than the forecast of $250.00K by 24.10%, and down by -69.13% from previous year's revenue.

The company reported a net income of $-13.66M.

Capricor Therapeutics, Inc reported a free cash flow of $-10.60M for its fiscal year, compared to $-6.82M a year ago.

The company ended the fiscal year with $318.16K in total debt, a decrease of -90.58% compared to the previous year.